PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21472241-1	2010	This study describes the symmetric synthesis of novel beta-lactams derived from chrysene directed towards their SAR, as well as their biological activities against several cancer cell lines in vitro.	beta-Lactams	54-66	sarcosine dehydrogenase	Homo sapiens	112-115	
29034069-3	2017	Molecular modeling studies are used to understand the observed SAR in the beta-lactam series.	beta-Lactams	74-85	sarcosine dehydrogenase	Homo sapiens	63-66	
28237762-0	2017	Synthesis, SAR and molecular docking study of novel non-beta-lactam inhibitors of TEM type beta-lactamase.	beta-Lactams	56-67	sarcosine dehydrogenase	Homo sapiens	11-14	
26541549-10	2015	When enterococci were also considered, all betalactam based regimens required combination with vancomycin or linezolid for a SAR > 95 %, whereas TGC based regimens were not compromised.	beta-Lactams	43-53	sarcosine dehydrogenase	Homo sapiens	125-128